Literature DB >> 14770278

In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes.

A García-Patterson1, L Erdozain1, G Ginovart2, J M Adelantado3, J M Cubero1, G Gallo1, A de Leiva1,4, R Corcoy5,6.   

Abstract

AIMS/HYPOTHESIS: This study analysed the relationship between congenital malformations (CM) and severity of gestational diabetes mellitus.
METHODS: A cohort of 2060 infants of mothers with gestational diabetes was studied. Universal screening and 3(rd) Workshop-Conference criteria were used to diagnose gestational diabetes. The severity of diabetes was assessed on the basis of previous hyperglycaemia, blood glucose values in diagnostic OGTT, area under the glucose curve, gestational age and HbA(1)c at diagnosis, insulin requirements during pregnancy, and OGTT after delivery. Potentially confounding variables (age, pre-pregnancy BMI, smoking) were considered. The relationship of potential predictors with CM was analysed with several multivariate logistic regression analyses.
RESULTS: The rate of CM was 6% for minor and 3.8% for major malformations (1.4% heart, 0.8% renal/urinary, 0.7% skeletal, 0.3% hypospadias, 0.2% central nervous system, 0.2% cleft lip/palate, 0.1% digestive tract, 0.3% other). In the final models, forward logistic regression analysis identified pre-pregnancy BMI as the predictor of CM (area under receiver operating characteristic curve 0.616); in the backward analysis additional predictors were 1-h blood glucose in diagnostic OGTT and gestational age at diagnosis (area under receiver operating characteristic curve 0.646). Both BMI and severity of gestational diabetes were predictors of heart and minor CM, whereas BMI predicted renal/urinary CM and severity of diabetes predicted skeletal CM. CONCLUSIONS/
INTERPRETATION: In these infants of mothers with gestational diabetes, severity of diabetes and pre-pregnancy BMI were predictors of CM, in accordance with the well-documented pathogenic role of BMI (in the general population) and hyperglycaemia (in diabetic pregnancy). BMI was the main predictor of more prevalent CM.

Entities:  

Mesh:

Year:  2004        PMID: 14770278     DOI: 10.1007/s00125-004-1337-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

Review 1.  The insulin family of peptides in early mammalian development.

Authors:  S Heyner; M Farber; I Y Rosenblum
Journal:  Curr Top Dev Biol       Date:  1990       Impact factor: 4.897

2.  Is maternal obesity a risk factor for open neural tube defects?

Authors:  J E Haddow; G E Palomaki
Journal:  Am J Obstet Gynecol       Date:  1995-01       Impact factor: 8.661

3.  Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers.

Authors:  E Miller; J W Hare; J P Cloherty; P J Dunn; R E Gleason; J S Soeldner; J L Kitzmiller
Journal:  N Engl J Med       Date:  1981-05-28       Impact factor: 91.245

4.  Maternal age and malformations in singleton births.

Authors:  L M Hollier; K J Leveno; M A Kelly; D D MCIntire; F G Cunningham
Journal:  Obstet Gynecol       Date:  2000-11       Impact factor: 7.661

5.  Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes.

Authors:  U M Schaefer-Graf; T A Buchanan; A Xiang; G Songster; M Montoro; S L Kjos
Journal:  Am J Obstet Gynecol       Date:  2000-02       Impact factor: 8.661

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

7.  Risk of neural tube defect-affected pregnancies among obese women.

Authors:  G M Shaw; E M Velie; D Schaffer
Journal:  JAMA       Date:  1996-04-10       Impact factor: 56.272

8.  Upstream AUGs in embryonic proinsulin mRNA control its low translation level.

Authors:  Catalina Hernández-Sánchez; Alicia Mansilla; Enrique J de la Rosa; G Elisabeth Pollerberg; Encarna Martínez-Salas; Flora de Pablo
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

9.  Transplacental passage of insulin complexed to antibody.

Authors:  W A Bauman; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

10.  CONGENITAL MALFORMATIONS IN NEWBORN INFANTS OF DIABETIC WOMEN. CORRELATION WITH MATERNAL DIABETIC VASCULAR COMPLICATIONS.

Authors:  L M PEDERSEN; I TYGSTRUP; J PEDERSEN
Journal:  Lancet       Date:  1964-05-23       Impact factor: 79.321

View more
  16 in total

1.  Proinsulin: much more than a hormone precursor in development.

Authors:  Catalina Hernández-Sánchez; Oscar Bártulos; Flora de Pablo
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

Review 2.  What neonatal complications should the pediatrician be aware of in case of maternal gestational diabetes?

Authors:  Delphine Mitanchez; Catherine Yzydorczyk; Umberto Simeoni
Journal:  World J Diabetes       Date:  2015-06-10

Review 3.  Proinsulin in development: New roles for an ancient prohormone.

Authors:  C Hernández-Sánchez; A Mansilla; E J de la Rosa; F de Pablo
Journal:  Diabetologia       Date:  2006-04-05       Impact factor: 10.122

Review 4.  Pre-pregnancy Obesity as a Modifier of Gestational Diabetes and Birth Defects Associations: A Systematic Review.

Authors:  Aimee S Parnell; Adolfo Correa; E Albert Reece
Journal:  Matern Child Health J       Date:  2017-05

5.  Evaluation of neonatally-induced mild diabetes in rats: Maternal and fetal repercussions.

Authors:  Isabela L Iessi; Aline Bueno; Yuri K Sinzato; Kristin N Taylor; Marilza Vc Rudge; Débora C Damasceno
Journal:  Diabetol Metab Syndr       Date:  2010-06-08       Impact factor: 3.320

Review 6.  New concepts in diabetic embryopathy.

Authors:  Zhiyong Zhao; E Albert Reece
Journal:  Clin Lab Med       Date:  2013-04-19       Impact factor: 1.935

7.  Should prevention of chronic kidney disease start before pregnancy?

Authors:  Guido Filler; Meera S Rayar; Orlando da Silva; Ilan Buffo; Dion Pepelassis; Ajay P Sharma
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

8.  GESTATIONAL DIABETES MELLITUS AND THE DEVELOPMENT OF CLEFT LIP / PALATE IN NEWBORNS.

Authors:  A Kozma; V Radoi; R Ursu; C L Bohaltea; H Lazarescu; S Carniciu
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

9.  Obstetric and perinatal outcomes in pregnancies complicated by Type 1 and Type 2 diabetes: influences of glycaemic control, obesity and social disadvantage.

Authors:  H R Murphy; S A Steel; J M Roland; D Morris; V Ball; P J Campbell; R C Temple
Journal:  Diabet Med       Date:  2011-09       Impact factor: 4.359

10.  Pre-pregnancy obesity and risk of congenital abnormalities of the kidney and urinary tract (CAKUT)-systematic review, meta-analysis and ecological study.

Authors:  Lyda Jadresić; Howard Au; Christopher Woodhouse; Dorothea Nitsch
Journal:  Pediatr Nephrol       Date:  2020-06-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.